Skip to main content
Health & Medicine

Fluid eMTBR-tau243 as a Biomarker of Mixed 3-Repeat and 4-Repeat Tau Pathology.

| Source: JAMA

Neurodegenerative diseases with abnormal tau protein aggregation in the brain (ie, tauopathies) can be classified by the tau isoform that accumulates: 3-repeat (3R), 4-repeat (4R), or mixed 3R/4R tauopathies, which include chronic traumatic encephalopathy (CTE), some forms of frontotemporal lobar degeneration, and Alzheimer disease (AD). The endogenously cleaved form of tau microtubule binding region containing the residue 243 (eMTBR-tau243) can be detected in cerebrospinal fluid (CSF) and blood

Neurodegenerative diseases with abnormal tau protein aggregation in the brain (ie, tauopathies) can be classified by the tau isoform that accumulates: 3-repeat (3R), 4-repeat (4R), or mixed 3R/4R tauopathies, which include chronic traumatic encephalopathy (CTE), some forms of frontotemporal lobar degeneration, and Alzheimer disease (AD). The endogenously cleaved form of tau microtubule binding region containing the residue 243 (eMTBR-tau243) can be detected in cerebrospinal fluid (CSF) and blood and has been associated with AD tau pathology, but its specificity and biological interpretation in non-AD tauopathies remains unclear. To evaluate biofluid eMTBR-tau243 in a range of tauopathies. This case-control study included 4 biorepositories based in the US that contributed CSF and plasma samples from participants with and without tauopathies, many of whom had antemortem biofluid samples paired with autopsy or genetically defined neuropathology. Samples were analyzed between August 2023 and December 2025. Data analysis occurred from August 2024 to July 2026. CSF and plasma eMTBR-tau243 concentrations measured using a mass spectrometry-based assay. Outcomes included mixed 3R/4R tauopathy (eg, AD and CTE) based on autopsy, frontotemporal lobar degeneration with MAPT variants (FTLD-MAPT), and CTE stage. Differences in biomarker levels between groups were evaluated using analysis of variance or analysis of covariance, and area under the receiver operating characteristic curve (AUC) was calculated to evaluate the discriminative performance of fluid eMTBR-tau243. Among the 229 participants (196 with CSF samples and 55 with plasma samples [22 with both]), mean (SD) age at fluid sample collection was 63 (13) years and 108 (47%) were female. Median (IQR) CSF eMTBR-tau243 was increased in 10 patients with AD (0.459 [0.246-0.801] fmol/mL) compared with 29 cognitively unimpaired controls (0.002 [0.001-0.005] fmol/mL) (adjusted P < .001), but other autopsy-confirmed non-AD tauopathies (which included 52 individuals with conditions including progressive supranuclear palsy and corticobasal degeneration) did not demonstrate an increase (0.015 [0.008, 0.039] fmol/mL). Six symptomatic FTLD-MAPT variant carriers with mixed 3R/4R tauopathy (R406W, V337M, and G389R) had increased median (IQR) CSF eMTBR-tau243 (0.140 [0.055-0.174] fmol/mL) compared with 15 4R tauopathy variant carriers including N279K and P301L (0.004 [0.001-0.044] fmol/mL) (P = .001). Median (IQR) plasma eMTBR-tau243 was increased in 11 patients with CTE (1.93 [0.42-3.68] fmol/L) compared with 20 cognitively unimpaired controls (0.29 [0.05-0.62] fmol/L) (adjusted P = .007), but did not increase as high as among 14 patients with AD (11.25 [2.29-19.38] fmol/L). Plasma eMTBR-tau243 distinguished CTE stage III and IV from controls (AUC, 0.97; 95% CI, 0.92-1.00), but not CTE stage I from controls (AUC, 0.64; 95% CI, 0.32-0.97). This study found that plasma and CSF eMTBR-tau243 were increased in mixed 3R/4R tauopathies including AD, high-stage CTE, and a subset of genetic FTLD-MAPT, compared with cognitively unimpaired controls. Further validation in larger cohorts is needed to determine the clinical utility of eMTBR-tau243 as a potential diagnostic biomarker for CTE and other tauopathies beyond AD.

Read the original source →

Related Stories

Health & Medicine

Homeostatic control of stem cell activity during intestinal regeneration.

Stem cells proliferate rapidly to maintain tissue turnover during regeneration, yet the mechanisms preventing hyperproliferation remain unclear. Here, we identified nuclear factor Y (NF-Y) as a transcriptional repressor that maintains intestinal stem cell (ISC) quiescence. NF-Y restricts ISC proliferation by occupying the promoters of epidermal growth factor receptor (EGFR) signaling components, including Egfr , Mkp3 , Raf , Ras , and pnt , through regulation dependent on the histone acetyltrans

Continue reading
Health & Medicine

Spatial transcriptomics reveals organizational properties of the mouse spinal cord and alterations in neuropathic pain.

The spinal cord integrates diverse somatosensory inputs and executes motor outputs through anatomically and functionally distinct circuits. Here, we employed spatially resolved single-cell transcriptomic profiling of the adult mouse spinal cord to gain insights into the organizational logic of the spinal cord. Our results reveal distinct spatial and laminar distributions of neuronal subtypes, including axial level and sex-specific differences. Many neuronal subtypes exhibit lamina-specific somat

Continue reading
Health & Medicine

Acute degradation of Pumilio proteins reveals a biphasic posttranscriptional regulatory hierarchy in embryonic stem cell fate decision.

Posttranscriptional regulation is critical for mammalian embryogenesis yet has been underexplored. We previously showed that RNA-binding Pumilio proteins (Pum1/2) are essential for early mouse embryogenesis and embryonic stem cell (ESC) functions. Here, using acute protein degradation systems combined with time-resolved RNA sequencing and enhanced crosslinking and immunoprecipitation, we delineate a two-phase regulatory hierarchy modulated by Pum1/2 in mouse ESCs. The first phase, occurring with

Continue reading
Health & Medicine

Elastic interactions of mechanically polarizable cells.

Cells mechanically interact through the deformations they generate in their surrounding extracellular matrix. We present an analytical theory of the elastic interactions between cells that actively adapt their forces in response to local deformations of their environment. Cells are represented as localized contractile force generators, modeled as polarizable point force dipoles, whose adaptive forces are determined self-consistently with those of surrounding cells. Analysis of the associated ela

Continue reading
Health & Medicine

ChREBP drives diabetic kidney disease, and its inhibition confers renal protection.

Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potent

Continue reading